Patent Application
20120114763
The present invention relates to methods for producing collagen/apatite composite membranes by biomimetic processes usefully applicable for guided bone or tissue regeneration and collagen/apatite composition membranes produced by the same methods.
Recently, tissue engineering has become the best solution for reconstruction of defective tissues in both medical and engineering fields on the basis of the developments up to now. One of the best developed fields is guided bone regeneration (GBR) or guided tissue regeneration (GTR). This is to use a barrier in a form of membrane to protect fibrous connective tissue from infiltrating into a site of defective bone or tissue.
Many researchers have tried to make materials very well suitable to the membranes for such use, but all the materials as tried up to now have advantages and shortcomings, respectively. For example, polytetrafluoroethylene (PTFE) membranes have been used as such barriers for GTR, but the PTFE membranes have the fatal shortcoming that they should be removed with secondary operation due to their bioinertness and they also have limitations of defective tissue sizes applicable to reconstruct new tissues.
In order to overcome these shortcomings, many researchers have suggested and studied resorbable membranes such as those of collagen and synthetic biodegradable polymers. Collagen, which is an inert natural protein found in human and animal skins, connective tissues, bones and teeth, has excellent biocompatibility and resorbability, but has poor mechanical properties. In addition, the solubility of pure collagen is generally too high. On the other hand, polylactide-based polymers have sufficient mechanical properties, but their cell affinities and dissolution rates are too low [Y. Aman, M. Ota, K. Sekiguchi, Y. Shibukawa, and S. Yamada, Evaluation of a poly-1-lactic acid membrane and membrane fixing pin for guided tissue regeneration on bone defects in dogs, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 97: 155-163; M. Asboe, E. M. Pinholt and E. Hjorting-Hansen, Healing of experimentally created defects: a review, British Journal of Oral and Maxillofacial Surgery 1995; 33: 312-318; Y. Park, Y. Ku, C. Chung and S. Lee, Controlled release of platelet-derived growth factor from porous poly(L-lactide) membranes for guided tissue regeneration, Journal of Controlled Release 1998; 51: 201-211; M. Kikuchi, Y. Koyama, T. Yamada, Y. Imamura, T. Okada, N. Shirahama, K. Akita, K. Takakuda and J. Tanaka, Development of guided bone regeneration membrane composed of β-ticalcium phosphate and poly(L-lactide-co-glycolide-co-ε-caprolactone) composites, Biomaterials 2004; 25: 5979-5986].
Considering these problems, some researchers have prepared composites of osteoconductive calcium phosphate ceramics and biodegradable synthetic polymers. For example, hydroxyapatite/poly(ε-caprolactone) composites [D. Choi, K. G. Marra and P. N. Kumta, Chemical synthesis of hydroxyapatite/poly(ε-caprolactone) composites, Materials Research Bulletin 2004; 39: 417-432], biodegradable Polyactive®/hydroxyapatite membrane [J. A. Jansen, J. E. de Ruijter, P. T. M. Janssen and Y. G. C. J. Paquay, Histological evaluation of biodegradable Polyactive®/hydroxyapatite membrane, Biomaterials 1995; 16: 819-827], β-ticalcium phosphate and poly(L-lactide-co-glycolide-co-ε-caprolactone) composites [M. Kikuchi, Y. Koyama, T. Yamada, Y. Imamura, T. Okada, N. Shirahama, K. Akita, K. Takakuda and J. Tanaka, Development of guided bone regeneration membrane composed of βticalcium phosphate and poly(L-lactide-co-glycolide-co-ε-caprolactone) composites, Biomaterials 2004; 25: 5979-5986] have been investigated. Although their feasibility for GBR has increased, they have a problem in the uniformity of the ceramic particles incorporated in the polymer matrix according to the particle size or amounts of particles. Moreover, the ceramic particles sometimes act as a defect factor and decrease the mechanical properties of composite membranes.
Another approach to composite membranes for GTR is to form hydroxyapatite in and on collagen membranes. To enhance the forming ability of membrane, many methods of collagen modification have been suggested [S. Rhee and J. Tanaka, Effect of citric acid on the nucleation of hydroxyapatite in a simulated body fluid, Biomaterials 1999; 20: 2155-2160; D. Lickorish, J. A. M. Ramshaw, J. A. Werkmeister, V. Glattauer and C. R. Howlett, Collagen-hydroxyapatite composite prepared by biomimetic process, J Biomed Mater Res 68A 2004; 19-27; A. Tampieri, G. Celotti, E. Landi, M. Sandri, N. Roveri and G. Falini, Biologically inspired synthesis of bone-like composite: Self-assembled collagen fibers/hydroxyapatite nanocrystals, J Biomed Mater Res 67A 2003; 618-625]. More recently, collagen/hydroxyapatite composites were made by the biomimetic approach. In this method, apatite crystals were precipitated and aligned along with collagen fiber direction. The advantage of this method is to make a nanoscale-ordered and homogeneous structure of composites. However, this process posed serious problems because self-assembled fibers were aggregated and became irregular particles [M. Kikuchi, S. Itoh, S. Ichinose, K. Shinomiya and J. Tanaka, Self-organization mechanism in a bone-like hydroxyapatite/collagen nanocomposite synthezed in vitro and its biological reaction in vivo, Biomaterials 2001: 22: 1705-1711; S. Itoh, M. Kikuchi, Y. Koyama, K. Takakuda, K. Shinomiya and J. Tanaka, Development of an artificial vertebral body using a novel biomaterial, hydroyapatite/collagen composite, Biomaterials 2002; 23: 3919-3926].
U.S. Pat. Nos. 6,300,315 and 6,417,166 disclosed a method for obtaining a sheet of mineralized collagen membrane by simultaneously adding calcium chloride solution and ammonium phosphate solution into collagen gel slurry and casting the precipitation on a filter paper. This method is characterized to use collagen slurry as starting material of collagen to precipitate apatite precipitation on the collagen and obtain the collagen membrane. Meanwhile, the method, in which collagen slurry is used to form apatite precipitation thereon, had already been disclosed by the previous U.S. Pat. No. 5,320,844 to the same inventor (which was registered and published before the filing dates of the above later patents), whereby this patent only suggested the composite as prepared by the method might be used as an alternative of light tissue, but suggest no membrane for GTR and preparing method therefor. This inventor described in the later patents that mineralized collagen had heretofore (up to the filing date) been prepared by freeze-drying to form a sponge structure or was alternatively prepared in solid block or granule form, however, none of these mineralized forms of collagen could be used as membrane barriers for GTR procedures and no collagen membrane suitable for GTR application suggested.
In the meantime, researches to alternate defective bones to artificial bone materials have considerably proceeded. Korean Patent Publication No. 2005-0083797 (which was published on Aug. 26, 2005, and was in Korean national phase of international publication No. WO 2004/041320 on May 21, 2004) disclosed cross-linked porous apatite/collagen composite useful as artificial bone material and manufacturing method therefor. This patent application was finally to obtain artificial bone material by the steps of mixing aqueous phosphate solution of collagen and dispersion of calcium hydroxide to obtain 8/2 by weight of apatite/collagen composite, preparing dispersion in a form of paste from such composite, gelatinizing such paste to form a molding and lyophilizing and cross-linking such molding. This patent application did not mention any membrane for GTR, but only suggested bone-alternative material in which apatite as main component compounded with collagen.
The object of the present invention is to provide a method for producing a collagen/apatite composite membrane useful as a barrier to protect fibrous connective tissues from infiltrating into a site of defective tissue or bone in guided tissue regeneration (GTR) or guided bone regeneration (GBR) procedures.
The object of the present invention is also to provide a collagen/apatite composite membrane produced by the same method as mentioned above.
The present invention provides a method for producing a membrane comprising collagen/apatite composite in which the apatite is uniformly precipitated on the collagen by biomimetic approach.
The method of the present invention comprises the steps of preparing aqueous solution containing a soluble calcium ion (calcium ion solution), preparing phosphate/collagen solution in which collagen is dissolved into aqueous solution (phosphate solution) containing soluble phosphate ion, preparing buffer solution adjusted with ph 7 or higher, adding the calcium ion solution and the phosphate/collagen solution into the buffer solution and stirring the mixture to form precipitation of collagen/apatite composite, and washing and filtering such precipitation of collagen/apatite composite on a filter paper and then lyophilizing the precipitation to obtain a collagen/apatite composite membrane.
The method of the present invention may further include the step of cross-linking the collagen of said collagen/apatite composite membrane. Such cross-linking of collagen may be performed by immersing said collagen/apatite composite membrane into EDC-NHS solution in alcohol in which 1-ethyl-3-(3-dimethyl aminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) is dissolved in alcohol. The alcohol used as a solvent in said EDC-NHS solution is preferably ethanol. The method of the present invention may also further include the steps of, after said cross-linking, recovering and washing said cross-linked membrane with pure water and then lyophilizing it. The method may also further include the step of adjusting the thickness of said membrane by drying said membrane in the condition of uniformly pressing the surface of said membrane at a wet atmosphere.
In the method of the present invention, said calcium ion solution and said phosphate/collagen solution is preferably prepared to allow the nominal component ratio of collagen and apatite, which could be obtained in the case if the reaction to form said precipitation of collagen/apatite composite were perfectly performed without any loss, to be a value in the range of 8:2˜6:4 by weight. Said calcium ion solution preferably is solution in which Ca(OH)2 is dissolved into water, and said phosphate/collagen solution preferably is solution in which collagen is dissolved into aqueous H3PO4 solution. Said step of forming the precipitation of said collagen/apatite composite is preferably performed on the condition that the mixture is kept at pH 7 or higher, and more preferably, at pH 9. Said buffer solution is preferably, tris-HCl buffer solution established at pH 9 and said step of forming the precipitation of said collagen/apatite composite is preferably performed on the condition that the mixture is kept at pH 9. Said steps of washing and filtering the precipitation of said collagen/apatite composite is preferably performed by the steps of separating such precipitation by means for separating solid and liquid, washing the precipitation and then casting the precipitation onto a filter paper, or said steps of washing and filtering is preferably performed by the steps of casting such precipitation onto a filter paper and then washing it on the filter paper. The apatite in said collagen/apatite composite is preferably, hydroxyapatite.
The method according to the present invention can allow to form a collagen/apatite composite membrane in which the crystals of apatite, in particular, hydroxyapatite are coated on and along with the collagen fiber direction without aggregation of self-assembled collagen fibers. Such composite membrane has excellent biological and mechanical properties such as biocompatibility, cell affinity, biodegradability and form stability, and therefore it can be used as a barrier for GTR. The method of the present invention can also allow the composite membrane to have microstructure enabling osteoblasts to be attached and proliferated well on the membrane, and can allow the properties of membrane to be controlled by adjusting its thickness in the formation of membrane, thereby providing a collagen/apatite composite membrane suitable to a needed use.
The present invention relates to a method for producing a collagen/apatite composite membrane by biomimetic approach.
In order to produce a collagen/apatite composite membrane in accordance with the method of the present invention, soluble calcium ion containing aqueous solution (calcium ion solution) is prepared. The calcium compound contained in the calcium ion solution is not particularly restricted if it is soluble into water and does not prohibit to precipitate apatite, and the examples in accordance with the present invention used calcium hydroxide [Ca(OH)2], in particular. Such calcium compound is dissolved into water with a needed amount at a concentration within the limit of solubility. The needed amount of calcium compound is determined in consideration to the needed component ratio of the collagen and apatite, which will be formed through precipitation, in the final membrane.
Phosphate/collagen solution in which collagen is dissolved into soluble phosphate ion containing aqueous solution (phosphate solution) is also prepared. The order for dissolutions of phosphoric acid or phosphate and collagen is not particularly restricted. The amounts of collagen and phosphate are determined in consideration to the needed component ratio of the collagen and apatite in the final membrane. The phosphate compound contained in the phosphate solution is not particularly restricted if it is soluble into water and does not prohibit to precipitate apatite, and the examples in accordance with the present invention used phosphoric acid (H3PO4), in particular. Such phosphate compound is dissolved into water with a needed amount at a concentration within the limit of solubility. The collagen used in the present invention is not particularly restricted, but preferably, is type I collagen. The concentration of collagen may be appropriately determined within the limit of solubility.
Meanwhile, as separate to these reactants, buffer solution adjusted to pH 7 or higher is prepared. The buffer solution is not particularly restricted if it does not prohibit precipitation of collagen and apatite and formation of apatite, but tris-HCl buffer solution was preferably used in the examples in accordance with the present invention. The pH of the buffer solution is more preferably established to about pH 9. If a reaction for precipitation of apatite is performed at about pH 9, then hydroxyapatite may be formed.
Into the prepared buffer solution are added the calcium solution and phosphate/collagen solution simultaneously or in order. The mixture of the reactants is vigorously stirred to induce co-precipitation of apatite and collagen. The pH of the reactant mixture is preferably kept at pH 7 or higher, and more preferably, at pH 9. The adjustment and maintenance of pH of the reactant mixture is achieved by using buffer solution, acid such as HCl and base such as NH4OH. The collagen/apatite composite formed by such co-precipitation has a microstructure in which apatite, especially hydroxyapatite is uniformly coated on collagen fiber in a form that C axis of hydroxyapatite is aligned along with the collagen fiber direction. Important consideration in the inducement of such co-precipitation is uniform precipitation and is to prevent aggregation of collagen by self-assemblage. These things are particularly important matters if the component ratio of collagen is high in the collagen/apatite composite. The nominal component ratio of collagen/apatite is 9/1˜5/5 by weight, preferably 8/2˜6/4 by weight in the composite membrane of the present invention. In this specification, the nominal component ratio of collagen/apatite does not means the actual ratio in the final collagen/apatite composite membrane, but means the ratio of collagen/apatite on the ideal condition that the co-precipitation reaction of the reactants for the co-precipitation of collagen and apatite proceeds perfectly with no loss.
If the composite membrane requires a high ratio of collagen, then the concentration of collagen in the reactant mixture become high to increase the possibility of collagen to be aggregated by its self-assemblage. In order to prevent this problem, collagen slurry may be used, but in this case, the uniform precipitation of apatite on collagen is limitedly achieved. In addition to the difficulty for the perfect uniformity of apatite precipitation due to the limitation to the uniformity of collagen slurry, the precipitation of apatite cannot be formed on the parts of collagen slurry not exposed, thereby it being difficult to obtain the composite membrane with the microstructure of uniform apatite precipitation on collagen. On these reasons, collagen is preferred to be dissolved into water in the present invention.
On the other hand, in the event that the co-precipitation of collagen and apatite is induced from dispersion of calcium salt with the limited solubility, there may occur non-uniformity of apatite precipitation distribution on collagen together with non-uniformity of the precipitated apatite composition. Therefore, the solution of the calcium salt with the limited solubility, particularly, calcium hydroxide, not the dispersion, is used in the present invention.
In the co-precipitation reaction system used in the present invention, the amount of collagen is larger than that of apatite, in particular, hydroxyapatite and preferably, the component ratio of collagen/apatite is in the range of 9/1˜5/5, and more preferably, in the range of 8/2˜6/4. The possibility of the little amount of apatite to contact or meet with the collagen is low in such reaction system, and therefore, nano-scale size of apatite particulates may be precipitated on the collagen uniformly and in a special orientation and the aggregation of the self-assembled collagen may be prevented in the solution. Such reaction system is consisted of the combination of calcium ion solution, collagen solution, buffer solution and pH adjustment and maintenance, and may be reinforced with vigorous stirring, low concentration, and long stirring and aging for 12 hours or more, preferably, for 24 hours or more. It is preferable that the reaction temperature should be about 40° C., and more precisely 37° C.
In the next, the precipitation of collagen/apatite composite formed by the biomimetic co-precipitation reaction system is washed, filtered and lyophilized to form collagen/apatite composite membrane without cross-linkage. At this time, the filtering is to cast the composite precipitation onto filter paper to form a sheet of membrane. The washing may be to wash the composite precipitation with pure water after casting it on filter paper, or may be to separate the precipitation by a solid-liquid separation means, for example, centrifugation or filtering and then to disperse it into water again and cast it onto filter paper. The lyophilization may be performed by any known method. It is generally known that the more the speed of lyophilization is, the smaller in tendency the size of pore in the porous body is and so, the pore size and form of the porous body obtained by lyophilization may be controlled with the lyophilization speed. Therefore, the present invention may also produce a composite membrane with suitable pore size for a certain use.
It is preferable to cross-link the prepared collagen/apatite composite membrane for enhancing form stability, namely, for providing stable form maintenance ability to resist against swelling in water when it is used in a body as well as for enhancing mechanical properties. The cross-linkage of composition membrane may be performed in a physical or chemical way, and may simply be performed by immersing the lyophilized composite membrane into a solution of cross-linking agent. The cross-linking agent may include agents in types of aldehydes, isocyanates, carbodiimides and others. The examples of the present invention used EDC-NHS solution in which 1-ethyl-3-(3-dimethyl aminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) are dissolved into ethanol. The use of alcohol such as ethanol as solvent may allow preventing the dissolution or loss of the composite membrane in the cross-linking reaction. After the cross-linking reaction, the composite membrane is washed to remove the remaining cross-linking agent and lyophilized again.
Meanwhile, the collagen/apatite composite membranes as prepared by the above method of the present invention are sheets of membrane formed by casting the precipitation of collagen/apatite composite from the co-precipitation reaction onto the filter papers with same area, but there is limitation on the uniformity of thickness although the thickness may be uniformly adjusted by the precipitation and filtration. Therefore, the present invention can dry the composite membrane, for example, on the condition or after the surface of membrane is uniformly pressed under wet atmosphere at 40° C. to obtain the composite membrane with uniform and needed thickness. At this time, the density and porosity of the composite membrane can be adjusted by the adjustment of thickness in the present invention, and therefore, the present invention can provide the composite membrane with the adjusted thickness suitable for a certain needed use.
Now, examples and further explanations of the present invention will be offered for the purpose of illustration, not for limitation of the scope of the present invention.
(1) Preparation of Collagen/Hydroxyapatite Composite Membrane
As starting materials, Ca(OH)2 (99.995%, Aldrich, USA), H3PO4 (99.999%, 85 wt % aqueous solution, Aldrich, USA), and Type I collagen (MW 300,000, RegenMed. Inc., Korea) were used. The precipitation method was modified from the biomimetic method by co-precipitation [M. Kikuchi, S. Itoh, S. Ichinose, K. Shinomiya and J. Tanaka, Self-organization mechanism in a bone-like hydroxyapatite/collagen nanocomposite synthesized in vitro and its biological reaction in vivo, Biomaterials 2001: 22: 1705-1711; B Y Yoon, H W Kim, S H Lee, C J Bae, Y H Koh, Y M Kong and H E Kim, Stability and cellular responses to fluorapatite-collagen composites, Biomaterials 2005; 26: 2957-2963]. Ca(OH)2 was dissolved in cold distilled water completely in the range of solubility. Separately, collagen was dissolved in the H3PO4 solution of which 59.7 mM was diluted in distilled water. Before the reaction, the tris-HCl buffer solution with pH 9 was prepared keeping the temperature at 37° C. by water bath. Both Ca(OH)2 and H3PO4/collagen solution was added at the same time into a reaction vessel containing the buffer solution. During the reaction, care was taken to maintain the pH at 9 using HCl and NH4OH. The amount of Ca, P and collagen were set to produce the final collagen/HA ratio of 80/20 and 60/40 (wt/wt). The mixture was stirred fast during 24 hrs at 37° C. in water bath. The precipitates were subsequently filtrated and washed over again until the volume was 50 ml and freeze-dried at −60° C. under vacuum.
As a reference, a pure collagen membrane was made by the same filtering method. Collagen was dissolved in 50 mM acetic acid solution. After the collagen solution was mixed with tris-HCl buffer until the pH to 9, the solution was aged at 37° C. during 24 hrs. The precipitated collagen fibers were filtrated, washed over again and lyophilized at −60° C. under vacuum.
(2) Cross-Linkage
Chemical cross-linking of collagen membranes was performed using 1-ethyl-3-(3-dimethyl aminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) [L. H. H. Olde Damink, P. J. Dijkstra, M. J. A. l van Luyn, P. B. van Wachem, P. Nieeuwenhuis and J. Feijen, Cross-linking of dermal sheep collagen using a water-soluble carbodiimide, Biomaterials 1996; 17: 765-773]. The membranes were immersed in 100 mM EDC 100 mM NHS solution in 95% ethanol for 24 hrs at room temperature. As a solvent of EDC and NHS, ethanol prevented the dissolution or loss of the membrane during the process [M. Chang and J. Tanaka, FT-IR study for hydroxyapatite/collagen nanocomposite cross-linked by glutaraldehyde, Biomaterials 2002; 23: 4811-4818]. The cross-linked membranes were carefully withdrawn and washed with sufficient distilled water for 5 min five times to remove the residual EDC and NHS. Afterward washing, the membranes were re-freezed and lyophilized at −60° C. under vacuum.
(1) Identification of Chemical Composite and Microstructure
The thermogravimetric analysis (TGA) was performed to determine the amount of hydroxyapatite on composites. Each membrane 20 mg was studied using a TG analyzer (TGA-1000, Rheometric Scientific, UK) and measurements were recorded from 30° C. to 900° C. with 10° C./min heating rate under air. The remnants were recognized as inorganic components, mainly hydroxyapatite. The phase of the composition was analyzed by X-ray diffraction (XRD, M18XHF-SRA, MAC Science, Yokohama, Japan) patterns with CuKα radiation within 25-35° (2θ) at a rate of 1°/min. Chemical analysis of the composites was conducted by a Fourier transform infrared (FT-IR) spectrometer (Nicolet Magma 550 series II, Midac, USA) over the range between 4000 and 400 cm−1 at 1 cm−1 resolution averaging 64 scans. From the analysis, cross-linking of membrane was confirmed [M. Chang and J. Tanaka, FT-IR study for hydroxyapatite/collagen nanocomposite cross-linked by glutaraldehyde, Biomaterials 2002; 23: 4811-4818]. The microstructure and nano-structure of the composites were observed by field-emission scanning electron microscopy (FE-SEM, JSM-6330F, JEOL, Tokyo, Japan) and transmission electron microscopy (TEM, CM-20, Philips Electron Optics, Netherlands).
(2) Mechanical Properties
Density of each type of specimens was measured and compared with theoretical density. The membranes, which had a wide range of thickness from 200 to 1000□, were cut into a square shape with dimensions 5×5 mm and weighed. Tensile strength and elastic modulus were assessed using a universal testing machine (Model 5565, Instron Corp., Danvers, Mass.). The membranes were warm-pressed to have uniform thickness of 500□ under wet condition and lyophilized at −6° C. under vacuum. The exact thickness of dried specimens was measured using a confocal laser scanning microscope (CLSM, OLS 1200, Olympus). Then the membranes were cut into a dumbbell shape with a length of 25 mm and inner width of 5 mm. A tensile force was applied at an extension rate of 1 mm/min. More than six specimens were tested for each condition.
(3) Degree of Swelling
The swelling degree of membranes was studied by the volume change before and after soaking. The volume of cross-linked collagen and collagen/HAp membranes was measured and then they were separately immersed in distilled water at room temperature for 24 hrs. After removal from water, they were laid on the moist tissue for 1 min until no dripping water was observed. The volume of the swollen membranes was measured and the degree of volume change was calculated by the following equation: volume change (%)=[(VsVd)/Vd]×100 where Vd is the volume of the dry membrane and Vs is the volume of the swollen membrane.
(4) In Vitro Cellular Assay
MC3T3-E1 preosteoblasts (ATCC, CRL-2593) were cultured in regular culture media consisting of α-modified minimum essential medium (α-MEM; Join Bio Innovation (JBI), Korea) supplemented with 10% heated-inactivated fatal bovine serum (FBS; GIBCO, USA) and 1% antibiotic/antimycotic (GIBCO, USA) in a humidified atmosphere of 5% CO2 at 37° C. Before the experiments, MC3T3 cells were trypsinized and plated on the specimens at a density of 1×105 cells/cm2 and cultured osteogenic media (regular culture media described above plus 10 mM β-glycerol phosphate and 50□/ml L-ascorbic acid (Sigma, USA)) before they were harvested at 1 and 3 days for cell morphology. The cell morphology was observed with SEM after fixing with glutaraldehyde (2.5%), dehydrating with graded ethanols (75, 90, 95 and 100%), critical point drying and gold coating.
(5) In Vitro Collagenase Degradation
The biological stability of the cross-linked collagen and composite membranes was evaluated by in vitro collagenase biodegradation test [L. Ma, C. Gao, Z. Mao, J. Zhou and J. Shen, Enhanced biological stability of collagen porous scaffolds by using amino acids as novel cross-linking bridges, Biomaterials 2004; 25: 2997-3004]. Each kind of membranes was incubated in phosphate buffered saline (PBS, pH 7.4) containing given concentrations of type I collagenase (273 U/mg, Sigma) at 37° C. during 24 hrs. The degradation was stopped by incubating the assay in an ice bath immediately. Following centrifugation at 1500 rpm for 10 min, the clear supernatant was hydrolyzed with 6M HCl at 110° C. for 24 hrs. The content of hydroxyproline released from the collagen molecules in the membranes was measured using ELISA method [W. D. Coasts, Jr, D. T. Cheung, B. Han, J. W Currier and D. P. Faxon, Ballon angioplsty significantly increases collagen content but does not alter collagen subtype I/III ratios in the atherosclerotic rabbit iliac model, J Mol Cell Cardiol 1996; 28: 441-446]. The biodegradation degree is defined as the percentage of the released hydroxyproline from the membranes to the completely degraded one with the same composition and weight. Also, the amount of degradable collagen in the solution was measured to find out the effect of HAp in the degradation process.
(6) Statistical Analysis
Data are expressed as the mean±standard deviation (SD). Statistical analysis was performed using the two-population Student's t-test. The significant level was set as p<0.05.
(1) Identification of the Compositions of Membranes
The amounts of HA in the collagen/hydroxyapatite (Col/HA) membranes were identified by TGA analyses as shown in
The yields of the formation/precipitation of HA could be calculated from the compositions of the final composite membranes calculated from the results of TGA. The nominal composition of 80/20 of Col/HA was considerably deviated from the actual composition of the composite membrane, which assumed to be resulted from the aggregation of self-assembled collagen fibers. It was difficult to find nano-scale fibers in the composite membrane with this composition by observation of the SEM morphology. Therefore, it is preferable that the composition of Col/HA in the present invention should be 80/20 or less.
As shown in
(2) Morphology of the Composite Membrane
As shown in
The composite membranes in accordance with the examples of the present invention have entirely dense surfaces with slight pores and porous cross-sectional structure with porous layers. Such dual structure allows the dense surface layer to prevent the infiltration of connective fibers into defective sites and the porous cross-sectional structure to induce differentiation of osteoblasts and to fill the connection of bones with the membrane in the pores of membrane.
(3) Mechanical Properties
The solid and dotted lines in
The results of
(4) Form Stability
Since the main environment in the human body is consisted of water, the behavior of the composite membrane in water also is an important factor. The one example of such behavior is volume change. It is reported that the natural polymers generally swell in water and therefore has high volume change. However the small volume change is better for the use of GTR. It is because the form may be easily destroyed when the volume change is high. In this term, hydroxyapatite positively affects the formability of the composite membrane. It could be recognized from
The swelling property of the collagen membranes are affected in accordance with the degree of cross-linkage. However,
(5) Biological Stability (Biodegradability)
Collagen can be decomposed by collagenase in a human body. Efforts have been made to increase the biological stability of collagen through the cross-linkage of collagen for preventing fast degradation of collagen. Such degradation rate is an important factor for the biodegradable membrane to be used in the procedures of GTR or GBR. Such degradation rate has to be controlled in consideration of the cure period for the regeneration of the defective bone. Many biodegradable membranes and some commercially available collagen membranes failed to repair the defective bones due to rapid collapse or inflammatory reaction.
The examples of the present invention could enhance the resistance against the collagenase by cross-linkage of collagen and composition of collagen with hydroxyapatite. The membranes used in the examples of the present invention went through the cross-linking reactions with the same levels. As shown in
(6) Biocompatibility (Cellular Activity)
As shown in
It can be expected from the observation and conclusion as explained above that the mineralized granulates occurring on the surface of the composite membrane in accordance with the examples of the present invention are to indicate that the composite membrane of the present invention will positively affect the differentiation of osteoblasts and repair the bone defect successfully.
The collagen/apatite composite membrane prepared in accordance with the present invention has excellent mechanical properties, biocompatibility and suitable biodegradability and therefore it can sufficiently play a role of the barrier to prevent connective fibers from infiltrating into the defective sites in the procedures of GTR and GBR and can help the differentiation of osteoblasts in the defective sites. Accordingly, the composite membrane of the present invention can be used for GTR and GBR.
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/KR05/03855 | 11/14/2005 | WO | 00 | 9/19/2008 |
